Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Conference News AHA 2012

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

Jason Kahn

November 11, 2012

Presentation AHA 2012

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Presenter: Jay H. Traverse

November 05, 2012

Presentation AHA 2012

Intracoronary infusion of BM-MNC early or late after AMI: 4 month results of the SWISS-AMI trial

Presenter: Daniel S?rder

November 05, 2012

News Conference News AHA 2012

Cell Therapy Trials Show Mixed Results at AHA 2012

November 05, 2012

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

Advertisement

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Intracoronary infusion of BM-MNC early or late after AMI: 4 month results of the SWISS-AMI trial

Cell Therapy Trials Show Mixed Results at AHA 2012

No LateTIME Benefit for Cell Therapy After Primary PCI

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content